Table 4 Surgical complications according to CD classification in at least two patients in all groups

From: Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Events, n (%)

Cam+nab-TP (n = 114)

Cam+TP (n = 116)

TP (n = 103)

Any grade

Grade ≥3

Any grade

Grade ≥3

Any grade

Grade ≥3

Any events

39 (34.2)

7 (6.1)

45 (38.8)

14 (12.1)

33 (32.0)

7 (6.8)

Pneumonia

12 (10.5)

0

21 (18.1)

1 (0.9)

15 (14.6)

2 (1.9)

Recurrent laryngeal nerve injury

11 (9.6)

0

11 (9.5)

1 (0.9)

9 (8.7)

1 (1.0)

Dysrhythmia

7 (6.1)

0

2 (1.7)

0

3 (2.9)

0

Pleural effusion

3 (2.6)

3 (2.6)

12 (10.3)

7 (6.0)

7 (6.8)

3 (2.9)

Anastomotic leak

3 (2.6)

1 (0.9)

5 (4.3)

2 (1.7)

6 (5.8)

1 (1.0)

Conduit necrosis

2 (1.8)

0

1 (0.9)

0

1 (1.0)

0

Respiratory failure

1 (0.9)

1 (0.9)

0

0

1 (1.0)

1 (1.0)

Intrathoracic abscess

1 (0.9)

1 (0.9)

0

0

1 (1.0)

0

Delirium

1 (0.9)

0

0

0

1 (1.0)

0

Septic shock

0

0

3 (2.6)

3 (2.6)

0

0

Atelectasis

0

0

1 (0.9)

0

1 (1.0)

1 (1.0)

Chylous leak

0

0

0

0

2 (1.9)

0

Delayed conduit emptying

0

0

0

0

2 (1.9)

1 (1.0)